Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 8801 - 8808 of 11540 results
FCC Modifies Cost Recovery Rules for Medical Device Tests and Proposes Greater Access to MedRadio Bands for Testing
July 13, 2015| Advisory| Viewpoint
FY2016 Massachusetts Budget Update: The Conference Committee Budget
July 13, 2015| Alert| Viewpoint
USCIS Resumes Premium Processing for H-1B Extensions
July 13, 2015| Alert| Viewpoint
Privacy Monday - July 13, 2015
July 13, 2015| Blog| Viewpoint
Delivery System Reform 2.0: Scaling Alternative Payment Models is the New Normal
July 13, 2015| Blog| Viewpoint
GMOs in the Hotseat: White House to Overhaul Regulatory Framework on Biotechnology
July 10, 2015| Blog| Viewpoint
DOL Questions About Duties Tests Should Concern Employers (SHRM)
July 10, 2015| Blog| Viewpoint
News & Press Releases
Mintz Recognized Among Top 100 Law Firms in Los Angeles by LA Times
November 20, 2024
Mintz was recognized among the “100 Top Law Firms in Los Angeles” by LA Times B2B Publishing. The feature was distributed in the LA Times Sunday edition and included in the annual Top Law Firms issue.
Mintz Announces Partnership with Lineal’s Amplify Technology Suite
November 19, 2024
Mintz has partnered with Lineal, a leader in legal technology and data review solutions to assist with client services delivery. The collaboration brings Lineal’s Amplify Suite—an advanced RelativityOne integration—into Mintz’s practice to enhance early data assessment (EDA), streamline modern data review, and manage strategic decision calls.
Mintz Advises Aspen Aerogels on $98M Follow-on Offering
November 19, 2024
Mintz advised Aspen Aerogels, Inc. (NYSE: ASPN), a technology leader in sustainability and electrification solutions, on a registered follow-on offering of 4,887,500 shares of its common stock, which included 637,500 shares pursuant to the underwriters’ option to purchase additional shares of its common stock. The price to the public in the offering was $20.00 per share and the gross proceeds to Aspen from the offering were approximately $98 million, before deducting underwriting discounts and commissions and estimated offering expenses.
Events
BIPLA International & Medical Devices Event: Global Strategic Considerations for Medical Device Portfolios
Boston, Massachusetts
Podcasts
Health Law Diagnosed – Women Leaders in Health Care: Investing in Women’s Health
October 11, 2024| Podcast|
Health Law Diagnosed – Women Leaders in Health Care: The Emerging Role of AI in Health Care
March 22, 2024| Podcast|